Combined with histone methyltransferase, EZH2 (Enhancer of Zeste homolog2) can suppress PD-L1 expression by increasing trimethylation of histone H3K27 at the promoter, which is a regulatory mechanism that depends on HIF-1α in lung cancer (39). This evidence concerns the gene HIF1A and lung carcinoma.